FEFU Int. Admission Office:
+7 (423) 265 24 24
(ext. 2209)
Merck, a leading science and technology company in healthcare, life science and performance materials, Far East Federal University (FEFU) and the FEFU Endowment Foundation concluded a tripartite memorandum of understanding. The parties plan to continue to cooperate in a strategic partnership format.
“Strategic cooperation with such a major regional player as Far Eastern Federal University, is an important step in the implementation of our strategy in Russia: the development of scientific and technological partnerships with the leading research and education centers, as well as the promotion of the transfer of technology and the development of innovative biotechnology and biopharmaceutical industries”, said Jürgen König, President and General Director, Merck Russia & CIS.
The aim of the future strategic partnership will be to improve the quality of education and to conduct joint educational and scientific research based on the FEFU School of Biomedicine and Medical Center. The parties plan to consider the possibility of organizing and conducting joint training courses in Biomedical Sciences on the FEFU campus or in the relevant departments of Merck.
“The partnership with Merck, a leading science and technology company in healthcare, life science and performance materials, provides new opportunities for Far Eastern Federal University to implement projects related to scientific research and the development of the advanced medicine technologies of the future,” pointed out Nikita Anisimov, FEFU Interim President. “We expect that the agreements reached will contribute to development of the university as the leading region's center of biomedicine specialization and the training of highly qualified personnel in this area. It is extremely important for us to have a tripartite partnership format between Merck, FEFU and the FEFU Endowment Foundation, which proves mutual interest in long-term cooperation.”
“The availability of highly qualified personnel in the region, both in science and industry, is in line with our business priorities, focused on cooperation with biopharmaceutical and biotechnological research centers and enterprises. That is why we are discussing the possibility of supporting the laboratory project for conducting scientific and educational activities,” explained Heinz Schmidt, the Head of Merck Life Science Russia & CIS.
The parties plan to assess the potential and available opportunities for co-investment with the involvement of the FEFU Endowment Foundation's resources in potentially promising joint projects under the Russian Federal Law No. 275 (FZ-275), and to develop a detailed roadmap for further cooperation.